John F. Sheridan - May 15, 2023 Form 4 Insider Report for TANDEM DIABETES CARE INC (TNDM)

Signature
/s/ Rachel Malina , Attorney-in-Fact for John F. Sheridan
Stock symbol
TNDM
Transactions as of
May 15, 2023
Transactions value $
-$92,947
Form type
4
Date filed
5/17/2023, 06:21 PM
Previous filing
Mar 1, 2023
Next filing
May 30, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TNDM Common Stock Award $15.3K +560 +3.74% $27.32 15.5K May 15, 2023 Direct F1
transaction TNDM Common Stock Options Exercise $0 +793 +5.1% $0.00 16.3K May 15, 2023 Direct
transaction TNDM Common Stock Tax liability -$8.84K -275 -1.68% $32.13 16.1K May 15, 2023 Direct F2
transaction TNDM Common Stock Options Exercise $0 +8.95K +55.71% $0.00 25K May 15, 2023 Direct
transaction TNDM Common Stock Tax liability -$99.4K -3.09K -12.38% $32.13 21.9K May 15, 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TNDM Restricted Stock Unit Options Exercise $0 -793 -11.12% $0.00 6.34K May 15, 2023 Common Stock 793 Direct F3, F4
transaction TNDM Restricted Stock Unit Options Exercise $0 -8.95K -33.33% $0.00 17.9K May 15, 2023 Common Stock 8.95K Direct F3, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. Amended and Restated 2013 Employee Stock Purchase Plan (ESPP), for the ESPP purchase period of November 16, 2022 through May 15, 2023. This transaction is also exempt under Rule 16b-3(c).
F2 Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.
F3 Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan).
F4 RSU granted on 5/18/2021 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.
F5 RSU granted on 5/25/2022 vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.